Imugene Limited

ASX:IMU.AX

0.044 (AUD) • At close November 14, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) AUD.

20242023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996199519941993
Revenue 011.77812.977.2324.1344.1271.8411.1641.5640.6390.5380.2070.2362.2270000.37500001.2920.1140003.8590.2780.18800
Cost of Revenue 5.842.2042.4071.9620.0820.0630.0030.0020.00100000000000000.1750.10700000000
Gross Profit -5.849.57410.5635.2694.0514.0641.8381.1621.5630.6390.5380.2070.2362.2270000.37500001.1170.0070003.8590.2780.18800
Gross Profit Ratio 00.8130.8140.7290.980.9850.9990.9990.99911111000100010.8650.06200011100
Reseach & Development Expenses 86.88530.86536.61215.3559.3647.6124.1482.4722.6981.910.4690.6030.2850.4920.5220.4661.3241.0770.8450.810.8860.9440000000000
General & Administrative Expenses 020.42814.06110.3025.5153.6031.2130.8941.0910.8750.7631.0840.5721.0530.9771.6880.8541.1380.5680.9720.7840.54801.57600000000
Selling & Marketing Expenses 00.5070.3350.155-0.0820.4260.4140.3190.4790.3410.0420.0510000.1980.038000.2480.25000.56200000000
SG&A 48.20518.22511.6548.3485.4334.7141.6271.2111.570.8750.8051.1350.5721.0530.9771.6880.8541.1380.5681.221.0340.54801.57600000000
Other Expenses 011.52812.8377.24.0744.2051.751.1431.4990.680.8840.1570.114-0.1720.3123.1720.3410.3730.170.2550.0430.509-0.466-1.298-4.401-4.903-4.518-3.8590.5930.7470.7660.262
Operating Expenses 135.09149.08948.26623.70414.79712.3265.7753.6834.2682.8851.3361.7391.4031.8882.1232.7572.563.0423.1522.5132.4412.4290.3282.578-4.401-4.903-4.5181.3930.8710.9350.7660.262
Operating Income -140.931-51.293-50.673-25.666-14.879-12.389-5.778-3.685-4.269-2.246-0.797-1.739-1.1670.339-2.123-2.757-2.56-3.041-3.152-2.513-2.917-2.4290.788-2.571-4.401-4.903-4.5183.859-0.593-0.747-0.766-0.262
Operating Income Ratio 0-4.355-3.907-3.549-3.599-3.002-3.139-3.166-2.729-3.516-1.481-8.394-4.9490.152000-8.118000-127,818.1050.61-22.5050001-2.133-3.97300
Total Other Income Expenses Net -13.3651.637-12.787.211-3.896-3.6410.0040.0140.021-0.195-1.3180.18-1.966-0.1590.3563.2480.4080.4790.3660.584-0.3520.384-1.57-1.471-0.018-0.027-0.028-6.041-3.651-0.766-0.138-0.066
Income Before Tax -154.296-49.656-50.483-25.687-14.642-11.903-5.774-3.671-4.248-2.441-2.116-1.56-3.1330.18-1.7650.253-2.15-2.561-2.439-2.117-2.786-2.044-0.782-4.041-4.419-4.93-4.546-2.182-4.244-1.513-0.904-0.328
Income Before Tax Ratio 0-4.216-3.892-3.552-3.542-2.884-3.137-3.153-2.716-3.822-3.931-7.526-13.2820.081000-6.838000-107,585.158-0.605-35.377000-0.565-15.266-8.04800
Income Tax Expense -4.615-11.742-12.614-7.232-4.134-4.127-1.841-1.164-1.517-0.1951.663-0.0232.08-0.236-0.23-0.398-0.239-0.257-0.252-2.117-2.786-2.044-0.782-4.041-4.419-4.93-4.546-2.182-4.244-1.513-0.904-0.328
Net Income -149.681-37.915-37.869-18.455-10.508-7.775-3.934-2.507-2.731-2.441-2.116-1.56-3.1330.416-1.5350.65-1.911-2.304-2.187-1.794-2.1160.699-0.782-4.041-4.419-4.93-4.546-2.182-4.244-2.135-0.8750.243
Net Income Ratio 0-3.219-2.92-2.552-2.542-1.884-2.137-2.153-1.746-3.822-3.931-7.526-13.2820.187000-6.15200036,792-0.605-35.377000-0.565-15.266-11.35600
EPS -0.021-0.006-0.007-0.004-0.003-0.002-0.002-0.001-0.002-0.002-0.003-0.005-0.0220.003-0.0110.004-0.014-0.017-0.017-0.015-0.019-0.019-0.059-1.6-1.84-2.27-2.59-1.33-2.92-1.53-0.830.83
EPS Diluted -0.021-0.006-0.007-0.004-0.003-0.002-0.002-0.001-0.002-0.002-0.003-0.005-0.0220.003-0.0110.004-0.014-0.017-0.017-0.015-0.019-0.019-0.059-1.6-1.84-2.27-2.59-1.33-2.92-1.53-0.830.83
EBITDA -147.978-47.425-48.062-23.719-14.554-11.833-5.772-3.669-4.247-0.195-2.624-1.743-0.9950.682-1.4220.596-1.806-2.695-2.093-1.964-1.617-2.2961.117-3.421-4.401-4.903-4.518-2.114-4.147-1.513-0.871-0.305
EBITDA Ratio 0-4.168-3.721-3.278-3.579-2.986-3.137-3.164-2.728-4.0870.66-8.3914.6370.306000-6.199000-120,857.737-0.957-29.945000-0.548-14.917-8.04800